产品编号 :
Cas No. :
CAS No. |
191114-48-4 |
|---|---|
英文名称 |
(3aS,4R,7R,9R,10R,11R,13R,15S,15aR)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-11-methoxy-3a,7,9,11,13,15-hexamethyl-1-(4-(4-(pyridin-3-yl)-1H-imidazol-1-yl)butyl)octahydro-2H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(1H,7H,9H)-tetraone |
别名 |
(1R,2R,4R,6S,7R,8R,10R,13R,14S)-7-[(2S,3R,4S,6R)-4-Dimethylamino-3-hydroxy-6-methyloxan-2-yl]oxy-13-ethyl-6-methoxy-2,4,6,8,10,14-hexamethyl-17-[4-(4-pyridin-3-ylimidazol-1-yl)butyl]-12,15-dioxa-17-azabicyclo[12.3.0]heptadecane-3,9,11,16-tetrone;KETEK;(3aS,4R,7R,9R,10R,11R,13R,15R,15aR)-4-Ethyloctahydro-11-Methoxy-3a,7,9,11,13,15-hexaMethyl-1-[4-[4-(3-pyridinyl)-1H-iMidazol-1-yl]butyl]-10-[[3,4,6-trideoxy-3-(diMethylaMino)-β-D-xylo-hexopyranosyl]oxy]-2H-oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(1H,7H,9H)tetrone;HMR 3647;RU 66647;2H-Oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(1H,7H,9H)-tetrone,4-ethyloctahydro-11-Methoxy-3a,7,9,11,13,15-hexaMethyl-1-[4-[4-(3-pyridinyl)-1H-iMidazol-1-yl]butyl]-10-[[3,4,6-trideoxy-3-(diMethylaMino)-b-D-xylo-hexopyranosyl]oxy]-,(3aS,4R,7R,9R,10R,11R,1;TELITHROMYCIN;TelithroMycin 90% |
标准英文名 |
(3aS,4R,7R,9R,10R,11R,13R,15S,15aR)-10-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-ethyl-11-methoxy-3a,7,9,11,13,15-hexamethyl-1-(4-(4-(pyridin-3-yl)-1H-imidazol-1-yl)butyl)octahydro-2H-[1]oxacyclotetradecino[4,3-d]oxazole-2,6,8,14(1H,7H,9H)-tetraone |
分子式 |
C43H65N5O10 |
分子量 |
812.02 |
精确分子量 |
811.47 |
SMILES |
CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@@H](C)[C@H]2N(CCCCN3C=NC(C4=CN=CC=C4)=C3)C(=O)O[C@]12C |
标准SMILES |
CN(C)[C@H]1C[C@@H](C)O[C@@H](O[C@@H]2[C@@H](C)C(=O)[C@@H](C)C(=O)O[C@H](CC)[C@@]3(C)OC(=O)N(CCCCN4C=C(N=C4)C4=CN=CC=C4)[C@@H]3[C@H](C)C(=O)[C@H](C)C[C@@]2(C)OC)[C@@H]1O |
用途 |
Telithromycin is a ketolide antibiotic used for the treatment of community-acquired pneumonia (CAP), bronchitis, pharyngitis, tonsillitis, and other respiratory tract infections caused by susceptible strains of bacteria, including Streptococcus pneumoniae (including penicillin- and erythromycin-resistant strains), Haemophilus influenzae, and Moraxella catarrhalis. It was the first ketolide approved for clinical use and exhibits potent activity against macrolide-resistant pathogens by binding to the 50S ribosomal subunit and domains II and V of 23S rRNA with higher affinity than erythromycin or clarithromycin. |
InChIKey |
LJVAJPDWBABPEJ-HIXZKHOGSA-N |
|
|
评论 |
|---|